全文获取类型
收费全文 | 563篇 |
免费 | 12篇 |
国内免费 | 9篇 |
专业分类
儿科学 | 31篇 |
妇产科学 | 4篇 |
基础医学 | 39篇 |
口腔科学 | 7篇 |
临床医学 | 80篇 |
内科学 | 38篇 |
皮肤病学 | 3篇 |
神经病学 | 41篇 |
特种医学 | 8篇 |
外科学 | 27篇 |
综合类 | 118篇 |
预防医学 | 85篇 |
眼科学 | 1篇 |
药学 | 96篇 |
中国医学 | 3篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 15篇 |
2022年 | 19篇 |
2021年 | 23篇 |
2020年 | 16篇 |
2019年 | 22篇 |
2018年 | 17篇 |
2017年 | 22篇 |
2016年 | 18篇 |
2015年 | 14篇 |
2014年 | 38篇 |
2013年 | 46篇 |
2012年 | 28篇 |
2011年 | 51篇 |
2010年 | 47篇 |
2009年 | 43篇 |
2008年 | 29篇 |
2007年 | 28篇 |
2006年 | 23篇 |
2005年 | 11篇 |
2004年 | 21篇 |
2003年 | 10篇 |
2002年 | 9篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1998年 | 1篇 |
1997年 | 6篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1984年 | 1篇 |
排序方式: 共有584条查询结果,搜索用时 15 毫秒
1.
2.
目的:观察早期大剂量应用抗坏血酸(维生素C)对重症急性胰腺炎(SAP)大鼠的核因子-!B(NF-!B)的影响,研究其作用机制。方法:将72只SAP模型SD大鼠随机分成3组,每组各24只。A组:由大鼠股静脉滴注生理盐水5 ml/kg。B组:大鼠股静脉滴注Vit C 15 mg/kg加生理盐水至5 ml/kg。C组:由大鼠股静脉滴注Vit C 150 mg/kg加生理盐水至5 ml/kg。另取8只SD大鼠作为正常对照组。各组分别于8 h和24 h处死8只大鼠,采血测淀粉酶、脂肪酶、维生素C(PV-C)、超氧化物歧化酶(SOD)、TNF-αI、L-6。大鼠处死时分别取胰头组织3份,一份组织HE染色,行光镜检查,按Kusske的方法,对水肿、炎症、出血和坏死分别评分;一份制成超薄切片,行电镜检查;另一份SP法进行免疫组化染色,检测NF-!B的表达。每组另外8只大鼠观察3 d内存活情况,计算3 d成活率。结果:各组大鼠3 d内的生存率为正常对照组100%(8/8),A组0%(0/8),B组12.5%(1/8),C组50%(4/8),C组的3 d生存率显著高于其他两组(P<0.05)。各组的4项病理学评分均高于正常对照组(P<0.01),C组的4项病理学评分均低于A、B组(P<0.05)。透射电镜检查示C组中分泌颗粒较少,其包膜完整、内质网轻度肿胀、线粒体清晰,未见大片坏死。SAP大鼠体内淀粉酶、脂肪酶、细胞因子TNF-α和IL-6的水平明显增高,血清SOD和P-VC降低,胰腺组织中NF-!B活化阳性胰腺细胞数明显增多。C组的血清淀粉酶和脂肪酶低于A、B组(P<0.05),SOD和P-VC水平高于A、B组(P<0.05),血清TNF-αI、L-6水平低于A、B组(P<0.05),胰腺组织NF-!B活化水平低于A、B组(P<0.05)。结论:早期大剂量应用Vit C有助于及时提高SAP大鼠的P-VC、E-SOD水平,降低体内淀粉酶、脂肪酶、TNF-αI、L-6水平,其作用机制可能与大剂量Vit C抑制SAP大鼠体内NF-!B活化、在整体水平上抑制细胞因子基因表达、有助于机体免受自由基和过量细胞因子的损伤及减轻胰腺组织的病理性改变等因素有关。 相似文献
3.
骨髓输液在PICU的应用探讨 总被引:7,自引:0,他引:7
目的 探讨骨髓输液在PICU的适应证、方法及临床效果。方法 选择PICU危重症建立静脉通道困难患儿 30例 ,采用 7号骨穿针或 7~ 9号头皮针于胫骨粗隆下 1~ 2cm穿刺、固定 ,接入医嘱液体 ,记录穿刺所需时间、入液速度及生命体征变化、并发症等。结果 2 8例 1次成功 ,2例用头皮针者有堵塞 ,换针后重新穿刺成功 ,穿刺、固定到接入液体平均时间 (30± 10 )s。速率 :一般压力 (8± 3)ml (kg体重·h) ,加压下 (17± 6 )ml (kg体重·h) ,所有病例均达到了医嘱要求。骨髓输液持续时间 3~ 2 2h ,无 1例出现并发症。结论 骨髓输液在PICU危重症抢救中可迅速建立液体通道 ,争取抢救时间。头皮针比骨髓穿刺针易于固定 ,使用更方便 相似文献
4.
Poor health and low cardiorespiratory fitness (CRF) contribute substantially to the shortened lifespan of individuals with schizophrenia spectrum disorders (SSDs). Increasing physical activity has demonstrated value; however, there are limited interventions that are accessible and adequately address motivational challenges. This paper reports on an open trial of Physical Activity Can Enhance Life (PACE-Life), a motivational theory-based manualized multicomponent walking intervention. The primary aim was to examine the feasibility of implementing PACE-Life through meeting the recruitment target (n = 14), attendance and adherence rates, and participant feedback. The secondary aim was to assess the impact of PACE-Life on intermediate targets (autonomous motivation and satisfaction of autonomy, relatedness, and competence needs), proximal outcomes (Fitbit steps/day and minutes spent walking), the primary outcome (CRF), and secondary outcomes (loneliness, symptoms, resting heart rate, blood pressure, weight, body mass index, and hip and waist circumference). Seventeen participants with SSDs enrolled in a 24-week open trial. Assessments occurred at baseline, mid-point, post-test, and one-month follow-up. The recruitment target was exceeded, the group attendance rate was 34%, Fitbit adherence rate was 54%, and participant feedback indicated satisfaction with the intervention as well as a positive group environment. There was a large improvement in the primary outcome of CRF with 77% of participants achieving clinically significant improvement at post-test. Small and medium effect size increases were observed in autonomous motivation and satisfaction of autonomy, relatedness, and competence needs. Fitbit data and secondary outcomes generally remained unchanged or worsened during the intervention. Results from this open trial indicate that PACE-Life leads to meaningful changes in CRF among people with SSDs. 相似文献
5.
César Cuevas-Lara Mikel Izquierdo Mikel L. Sáez de Asteasu Robinson Ramírez-Vélez Fabiola Zambom-Ferraresi Fabricio Zambom-Ferraresi Nicolás Martínez-Velilla 《Journal of the American Medical Directors Association》2021,22(2):364-371.e1
ObjectivesTo examine the effectiveness of game-based interventions compared with usual care on health-related outcomes for acutely hospitalized older patients.DesignSystematic review of randomized controlled trials (RCT) and nonrandomized trials.Setting and ParticipantsAdults aged 65 years or older admitted to an Acute Care for Elderly unit were selected.MeasuresHealth-related outcomes (eg, functional capacity, quality of life, adherence to treatment).ResultsFour RCTs were included in the review. The interventions were based on the implementation of serious-game programs using Nintendo Wii in acute medical patients. Across the included studies, no significant differences were observed between groups on functional capacity and health-related quality of life. Significant differences were found between groups on the adherence to treatment (in favor of the control group), but no differences were obtained in other outcomes such as enjoyment and motivation.Conclusions and ImplicationsIn general, there is very limited evidence for the efficacy to reach conclusions about the effects of game-based interventions on health-related outcomes in acutely hospitalized older patients. Future studies are needed to improve our knowledge in the field; however, we consider that these strategies should be considered in the future complementary to usual care. 相似文献
6.
目的 :为了探讨一种不仅能有效降压 ,使用方便而且副作用少的一种降压药物。方法 :选择老年重症高血压患者6 0例 ,随机分成舌下含服卡托普利组和硝苯地平组 ,随时相观察血压、脉搏、心电图、临床症状改善情况及药物的副作用等。结果 :两组间降压总疗效无显著性差异 (P>0 .0 5 ) ,但血压下降高峰值比较 ,差异非常显著 (P<0 .0 1) ;卡托普利组用药 5 m in心率即开始减慢 ,30 min心率减慢达高峰 ,而硝苯地平组用药 5 min心率即开始增快 ,30 min心率增快达高峰 ,两组分别与用药前比较差异非常显著 (P<0 .0 1)。卡托普利组除感味苦外无其他不良反应 ,而硝苯地平组出现不同程度的颜面潮红、心悸、心绞痛以及心电图出现心肌缺血改变等副作用。结论 :舌下含服卡托普利治疗老年重症高血压 ,降压效果好 ,持续时间长 ,副作用少 ,优于硝苯地平 相似文献
7.
Margje Sinnema Marian A. Maaskant Henny M.J. van Schrojenstein Lantman-de Valk Harm Boer Leopold M.G. Curfs Constance T.R.M. Schrander-Stumpel 《European journal of medical genetics》2013,56(8):397-403
IntroductionAdults with Prader–Willi syndrome (PWS) have an increased occurrence of several medical conditions. We report on the consequences of high morbidity rates such as prevalence rate of hospital admissions, medication use and surgery in a Dutch cohort of adults with PWS. Special attention is paid to causes and symptoms of serious illness.MethodParticipants were contacted via the Dutch Prader–Willi Parent Association and through physicians specializing in persons with ID. The persons with PWS and their main caregivers were visited at home. Information was collected through semi-structured interviews on 102 adults with PWS.ResultsThe need for medical care in the neonatal period is associated with hypotonia and feeding problems. Hospital admissions for respiratory tract infections are frequent. During childhood most hospital admissions were due to PWS syndrome specific surgery. During adolescence hospital admissions occurred for scoliosis surgery and endocrine evaluations. At adult age, hospitalization was associated with inguinal hernia surgery, diabetes mellitus, psychosis, erysipelas, water and drug intoxications. In the older group, respiratory infections were again the main reason for hospital admissions. Frequently used medications at adult age included psychotropics, laxatives, anti-diabetics and dermatologic preparations. Abnormal drinking patterns, problems with anesthesia, decreased ability to vomit, abnormal pain awareness and unpredictable fever responses were frequent and often lead to delayed diagnoses of serious conditions.DiscussionPeople with PWS are frequent users of medical-care. Reasons for hospitalization and medication use are age specific. Knowledge on the different presentation of symptoms in people with PWS is needed. In case of unexplained illness, disturbances of consciousness and behavioral changes in people with PWS, an infection should be ruled out in the first place. Information from this study may help in preventing conditions and recognizing conditions in an early stage. Adequate preventive management and treatment of PWS related morbidity, could reduce medical care use in the long term and could improve quality adjusted life years. 相似文献
8.
9.
10.
体外无创性临时心脏起搏的临床应用 总被引:2,自引:0,他引:2
目的 评价体外无创性临时心脏起搏 ( ENCP)对心脏骤停及急性严重缓慢性心律失常的抢救效果、安全性。方法 19例心脏骤停患者和 18例有严重临床症状缓慢性心律失常患者紧急行 ENCP。结果 所有病人均在 1~ 5 min内在床边得到 ENCP。心脏骤停组 12例起搏成功 ,其中 5例复苏 ,起搏成功者平均起搏阈值 ( 10 5 .2± 15 .6) m A,起搏成功率 63 .1% ,起搏成功并复苏2 6.3 %。严重缓慢性心律失常组 17例 ENCP后临床症状迅速明显改善 ,平均起搏阈值 ( 75 .3± 2 1.5 ) m A,起搏成功率 94.4%。严重缓慢性心律失常组的起搏成功率明显高于心脏骤停组 ,起搏阈值明显低于心脏骤停组。所有患者起搏过程中均出现与起搏脉冲同步的胸部肌肉抽动 ,但只有 1例因胸痛在 ENCP维持下安装了经静脉临时心脏起搏器 ,其余病人虽有不适 ,均能接受 ENCP。所有 ENCP患者均未发现皮肤、软组织损伤及严重心律失常等不良反应。结论 体外起搏是心脏骤停、急性严重缓慢性心律失常行之有效的治疗手段。 相似文献